Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms is a research paper published in Research and Practice in Thrombosis and Haemostasis (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: UL1 TR001866
National Institute of Neurological Disorders and Stroke
Grant: NS102721
National Institute on Aging
Grant: AG069987
NIA NIH HHS
Grant: R01 AG069987
NIA NIH HHS
Grant: RF1 AG069987
NINDS NIH HHS
Grant: R01 NS102721
National Institutes of Health
Grant: 5UL1TR001866-07
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
National Institutes of Health
Grant: 5R01NS102721-02
Role of the Contact System in Alzheimer's Disease
National Institutes of Health
Grant: 4R01AG069987-02
Anti-high molecular weight kininogen antibody for Alzheimer's disease diagnosis and therapy
May and Samuel Rudin Family Foundation
FWCI
0.82
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals